Joel Lexchin

(MENAFN- The Conversation) Dr. Lexchin has been writing and publishing about pharmaceutical policy issues for the past 30 years. He is the author or co-author of over 140 peer-reviewed papers on a wide range of topics in this area, including: drug regulation, pharmacosurveillance, drug promotion, research and development, access to medications in developing countries and physician prescribing behaviour. He has been a consultant on these and other issues to the Ontario provincial government, various parts of the Canadian federal government, the government of New Zealand, the Australian National Prescribing Service and the World Health Organization.

• –present Affiliate - pharmaceutical policy, University of Sydney

• 1977  University of Toronto, MD

MENAFN11052021000199003603ID1102067443